Episode 98: How can we bring prenatal screening to the 21st century?

Samantha Leonard, International Senior Medical Director, Natera, Texas, US, discusses prenatal screening exploring essential questions surrounding this topic, from how prenatal screening tests work to the future of genetic screening technology.

 

This podcast has been funded by Natera. The tests described have been developed and performance characteristics determined by the CLIA-certified laboratory performing the test. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). Although FDA is exercising enforcement discretion of premarket review and other FDA legal requirements for laboratory-developed tests in the US, certification of the laboratory is required under CLIA to ensure the quality and validity of the tests. CAP accredited, ISO 13485 certified, and CLIA certified 2022 Natera, Inc. All Rights Reserved.